Inventor · disambiguated record
Joseph Foss
Also filed as: FOSS JOSEPH · FOSS JOSEPH F
9 granted patents·16 pending applications·500 citations·filing 1997–2024
89Inventor score
Top patents by PatentIndex Score
25 records- 0196US6608075B2Use of methylnaltrexone and related compoundsUNIV CHICAGO·Filed 2001·Granted Aug 19, 2003·88 cites·38 claims
- 0295US5972954AUse of methylnaltrexone and related compoundsARCH DEV CORP·Filed 1997·Granted Oct 26, 1999·222 cites·46 claims
- 0393US6559158B1Use of methylnaltrexone and related compounds to treat chronic opioid use side affectsUR LABS INC·Filed 2000·Granted May 6, 2003·79 cites·43 claims
- 0493US6274591B1Use of methylnaltrexone and related compoundsFiled 1998·Granted Aug 14, 2001·110 cites·30 claims
- 0584US12365609B2Sterile and/or purified fluid and/or solution delivery systemCLEVELAND CLINIC FOUND·Filed 2024·Granted Jul 22, 2025·0 cites·8 claims
- 0675US2009312359A1Use of methylnaltrexone and related compounds for treatment of gastrointestinal dysfunction induced by endogenous opioidsFOSS JOSEPH F·Filed 2008·Application pending·0 cites
- 0773US11021378B2Sterile and/or purified fluid and/or solution delivery systemCLEVELAND CLINIC FOUND·Filed 2016·Granted Jun 1, 2021·1 cites·25 claims
- 0871US11981588B2Sterile and/or purified fluid and/or solution delivery systemCLEVELAND CLINIC FOUND·Filed 2021·Granted May 14, 2024·0 cites·12 claims
- 0968US2025082624A1Methods of treating cognitive impairmentNEUROTHERAPIA INC·Filed 2024·Application pending·0 cites
- 1067US2010087472A1Use of methylnaltrexone and related compound to treat constipation in chronic opioid usersFOSS JOSEPH F·Filed 2009·Application pending·0 cites
- 1164US10526318B2Oral cannabinoid receptor modulator formulationsCLEVELAND CLINIC FOUND·Filed 2018·Granted Jan 7, 2020·0 cites·2 claims
- 1264US2004167148A1Oral use of methylnaltrexone and related compounds to treat constipation in chronic opioid usersFiled 2004·Application pending·0 cites
- 1364US2004162306A1Use of methylnal trexone and related compounds to treat constipation in chronic opioid usersFiled 2004·Application pending·0 cites
- 1461US2020087288A1Oral cannabinoid receptor modulator formulationsCLEVELAND CLINIC FOUND·Filed 2019·Application pending·0 cites
- 1560US2003158220A1Use of methylnaltrexone and related compounds to treat chronic opioid use side effectsFiled 2003·Application pending·0 cites
- 1660US2003065003A1Use of methylnaltrexone and related compoundsUNIV CHICAGO·Filed 2002·Application pending·0 cites
- 1759US2012277260A1Use of methylnaltrexone and related compounds to treat constipation in chronic opioid usersFOSS JOSEPH F·Filed 2012·Application pending·0 cites
- 1858US2012190702A1Use of methylnaltrexone and related compounds to treat constipation in chronic opioid usersFOSS JOSEPH F·Filed 2011·Application pending·0 cites
- 1958US2005048117A1Use of methylnaltrexone and related compoundsFiled 2004·Application pending·0 cites
- 2057US2004162307A1Use of methylnaltrexone and related compounds to induce laxation in chronic opioid usersFiled 2004·Application pending·0 cites
- 2157US2004162308A1Use of methylnaltrexone and related compounds for treatment of constipation caused by endogenous opioidsFiled 2004·Application pending·0 cites
- 2257US2004167147A1Oral use of methylnaltrexone and related compounds to induce laxation in chronic opioid usersFiled 2004·Application pending·0 cites
- 2355US11097965B2Multiple-bore solute cartridge carrierCLEVELAND CLINIC FOUND·Filed 2016·Granted Aug 24, 2021·0 cites·14 claims
- 2455US2003187010A1Use of methylnaltrexone and related compounds to treat chronic opioid use side effectsFiled 2003·Application pending·0 cites
- 2547US2006211733A1Methods of preventing and treating opioid bowel dysfunctionGLAXO GROUP LTD·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Foss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →